🇺🇸 FDA
Patent

US 7579451

Oligonucleotides comprising a modified or non-natural nucleobase

granted A61KA61K31/7115

Quick answer

US patent 7579451 (Oligonucleotides comprising a modified or non-natural nucleobase) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/7115